Recent Publications in Addiction Medicine

Recent publications

• Scaling up a brief alcohol intervention to prevent HIV infection in Vietnam: a cluster randomized, implementation trial. Bartels SM, Phan HTT, Hutton HE, Nhan DT, Sripaipan T, Chen JS, Rossi SL, Ferguson O, Nong HTT, Nguyen NTK, Giang LM, Bui HTM, Chander G, Sohn H, Kim S, Tran HV, Nguyen MX, Powell BJ, Pence BW, Miller WC, Go VF. Implement Sci. 2024 Jun 12;19(1):40. doi: 10.1186/s13012-024-01368-6. PMID: 38867283. Clinical Trial.

• Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial. Bobb JF, Idu AE, Qiu H, … Caldeiro RM, Tsui JI, Burganowski RP, Weinstein ZM, Murphy SM, Hyun N, Bradley KA. Drug Alcohol Depend. 2024 Aug 1;261:111350. doi: 10.1016/j.drugalcdep.2024.111350. Epub 2024 Jun 10. PMID: 38875880 Clinical Trial.

• Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cure. Lopes SS, Pericot-Valverde I, Dotherow JE, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Karasz A, Arnsten J, Moschella P, Heo M, Litwin AH; HERO study group. Drug Alcohol Depend. 2024 Jul 6;262:111384. doi: 10.1016/j.drugalcdep.2024.111384. Online ahead of print. PMID: 38991632.

• Differences in internalized HIV stigma across subpopulations of people with HIV in care across the United States. Drumright LN, Johnson MO, Mayer KH, Christopoulos K, Cachay E, Crawford TN, Whitney BM, Dai M, Ruderman SA, Mixson LS, Keruly JC, Chander G, Saag MS, Kitahata MM, Moore RD, Willig AL, Eron JJ, Napravnik S, Nance RM, Hahn A, Ma J, Bamford L, Fredericksen RJ, Delaney JAC, Crane HM. AIDS. 2024 Jul 1;38(8):1206-1215. doi: 10.1097/QAD.0000000000003864. Epub 2024 Feb 9. PMID: 38349228.

• Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain. Rodríguez MN, Colgan DD, Leyde S, Pike K, Merrill JO, Price CJ. Subst Abuse Treat Prev Policy. 2024 May 3;19(1):25. doi: 10.1186/s13011-024-00608-8. PMID: 38702783. Clinical Trial.

• Evaluation of respondent-driven sampling in seven studies of people who use drugs from rural populations: findings from the Rural Opioid Initiative. Rudolph AE, Nance RM, Bobashev G, Brook D, Akhtar W, Cook R, Cooper HL, Friedmann PD, Frost SDW, Go VF, Jenkins WD, Korthuis PT, Miller WC, Pho MT, Ruderman SA, Seal DW, Stopka TJ, Westergaard RP, Young AM, Zule WA, Tsui JI, Crane HM, Whitney BM, Delaney JAC. BMC Med Res Methodol. 2024 Apr 23;24(1):94. doi: 10.1186/s12874-024-02206-5. PMID: 38654219.

• Priorities for HIV and chronic pain research: results from a survey of individuals with lived experience. Robinson-Papp J, Lawrence S, Wadley A, Scott W, George MC, Josh J, O'Brien KK, Price C, Uebelacker L, Edelman EJ, Evangeli M, Goodin BR, Harding R, Nkhoma K, Parker R, Sabin C, Slawek D, Tsui JI, Merlin JS. AIDS Care. 2024 Apr 8:1-11. doi: 10.1080/09540121.2024.2334358. Online ahead of print. PMID: 38588701.

• The association of changes in depression severity after the onset of the COVID-19 pandemic and viral nonsuppression among people with HIV. Verinumbe T, Lesko CR, Moore RD, Fojo AT, Keruly J, Snow LN, Hutton H, Chander G, Pytell JD, Falade-Nwulia O. AIDS. 2024 May 1;38(6):887-894. doi: 10.1097/QAD.0000000000003828. Epub 2023 Dec 29. PMID: 38170505.

• A qualitative exploration of the use of telehealth for opioid treatment: Implications for nurse-managed care. Heidari O, Winiker AK, Pollock S, Sodder S, Tsui JI, Tobin KE. J Clin Nurs. 2024 Mar 18. doi: 10.1111/jocn.17125. Online ahead of print. PMID: 38500003.

• Contemporary Management and Outcomes of Veterans Hospitalized With Alcohol Withdrawal: A Multicenter Retrospective Cohort Study. Ronan MV, Gordon KS, Skanderson M, Krug M, Godwin P, Heppe D, Hoegh M, Boggan JC, Gutierrez J, Kaboli P, Pescetto M, Guidry M, Caldwell P, Mitchell C, Ehlers E, Allaudeen N, Cyr J, Smeraglio A, Yarbrough P, Rose R, Jagannath A, Vargas J, Cornia PB, Shah M, Tuck M, Arundel C, Laudate J, Elzweig J, Rodwin B, Akwe J, Trubitt M, Gunderson CG. J Addict Med. 2024 Mar 7. doi: 10.1097/ADM.0000000000001297. Online ahead of print. PMID: 38452185.

• Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study. Lopes SS, Pericot-Valverde I, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Karasz A, Arnsten J, Moschella P, Heo M, Litwin AH. BMC Infect Dis. 2024 Feb 23;24(1):251. doi: 10.1186/s12879-024-09124-3. PMID: 38395747.

• Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems. Tsui JI, Rossi SL, Cheng DM, Bendiks S, Vetrova M, Blokhina E, Winter M, Gnatienko N, Backonja M, Bryant K, Krupitsky E, Samet JH. PLoS One. 2024 Feb 26;19(2):e0297948. doi: 10.1371/journal.pone.0297948. eCollection 2024. PMID: 38408060. Clinical Trial.

• Association of Alcohol Use with COVID-19 Infection and Hospitalization Among People Living with HIV in the United States, 2020. Xia C, Chander G, Hutton HE, McCaul ME, Delaney JA, Mayer KH, Jacobson JM, Puryear S, Crane HM, Shapiro AE, Cachay ER, Lau B, Napravnik S, Saag M, Lesko CR. AIDS Behav. 2024 Feb 29. doi: 10.1007/s10461-024-04301-6. Online ahead of print. PMID: 38421512.

• Mental Health Distress Is Associated With Higher Pain Interference in Patients With Opioid Use Disorder Stabilized on Buprenorphine or Methadone. Leyde S, Price CJ, Colgan DD, Pike KC, Tsui JI, Merrill JO. Subst Use Addctn J. 2024 Feb 7:29767342241227402. doi: 10.1177/29767342241227402. Online ahead of print. PMID: 38327009.

• Optimal Hepatitis C Treatment Adherence Patterns and Sustained Virologic Response. among People Who Inject Drugs: The HERO Study. Heo M, Norton BL, Pericot-Valverde I, Mehta SH, Tsui JI, Taylor LE, Lum PJ, Feinberg J, Kim AY, Arnsten J, Sprecht-Walsh S, Page K, Litwin AH; HERO Study Group; National Stakeholder Advisory Board. J Hepatol. 2024 Jan 17:S0168-8278(23)05374-6. doi: 10.1016/j.jhep.2023.12.020. Online ahead of print. PMID: 38242324.

• Internal Medicine Resident Addiction Training at the Veteran's Health Administration: A Qualitative Evaluation of Site Directors' Response to the 2022 ACGME Requirements. Richardson C, Daniels K, Confer A, Saxon AJ, Gordon AJ, Liberto J, Albanese AP, Renner J, Edens E, Kennedy AJ. J Gen Intern Med. 2024 Feb 1. doi: 10.1007/s11606-024-08639-4. Online ahead of print. PMID: 38302815.

• High Seroprevalence of Hepatitis C Virus Among Cisgender Women Who Exchange Sex in the Seattle, Washington Area. Barry MP, Corcorran MA, Tsui JI, Moreno C, Buskin SE, Guthrie BL, Glick SN. Subst Use Addctn J. 2024 Jan;45(1):81-90. doi: 10.1177/29767342231208936. PMID: 38258855.

• Venous Thromboembolism Among People With HIV: Design, Implementation, and Findings of a Centralized Adjudication System in Clinical Care Sites Across the United States. Crane HM, Nance RM, Ruderman SA, Haidar L, Tenforde MW, Heckbert SR, Budoff MJ, Hahn AW, Drumright LN, … Saag MS, Kitahata MM, Crothers KA, Delaney JAC. J Acquir Immune Defic Syndr. 2024 Feb 1;95(2):207-214. doi: 10.1097/QAI.0000000000003339. PMID: 37988634.

• Perspectives of clinical stakeholders and patients from four VA liver clinics to tailor practice facilitation for implementing evidence-based alcohol-related care. Soyer EM, Frost MC, Fletcher OV, Ioannou GN, Tsui JI, Edelman EJ, Weiner BJ, Bachrach RL, Chen JA, Williams EC. Addict Sci Clin Pract. 2024 Jan 10;19(1):3. doi: 10.1186/s13722-023-00429-3. PMID: 38200496.

• Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugs. JI Tsui, AJ Gojic, KA Pierce, EL Tung, NC Connolly, AC Radick, RR Hunt, R Sandvold, K Taber, M Ninburg, RH Kubiniec, JD Scott, RN Hansen, JD Stekler, EJ Austin, EC Williams, SN Glick. Drug and Alcohol Dependence Reports. Volume 10, March 2024, 100213.

• Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study. Pericot-Valverde I, Lopes SS, Nahvi S, Thrasher JF, Karasz A, Taylor LE, Mehta SH, Lum PJ, Tsui JI, Page K, Feinberg J, Kim AY, Norton BL, Arnsten JH, Fernandez-Artamendi S, Heo M, Litwin A; HERO Research Group. Open Forum Infect Dis. 2023 Oct 5;10(11):ofad498. doi: 10.1093/ofid/ofad498. PMID: 38023556; PMCID: PMC10644781.

• Stimulant Co-use Is Associated With Patient-directed Discharges in Hospitalized Patients with Opioid Use and Injection Drug Use Related Infections. Liu AW, Yang WT, Glick SN, Kim HN, Beieler AM, Lan KF, Dhanireddy S, Tsui JI. J Addict Med. 2023 Nov-Dec 01;17(6):746-747. doi: 10.1097/ADM.0000000000001226. Epub 2023 Sep 20. PMID: 37934554.

• Evaluating the Sick Quitting Hypothesis for Frailty Status and Reducing Alcohol Use Among People With HIV in a Longitudinal Clinical Cohort Study. Ruderman SA, Drumright LN, Delaney JAC, Webel AR, Fitzpatrick AL, Whitney BM, Nance RM, Hahn AW, Ma J, … Lesko C, Chander G, Crane HM, Odden MC. J Assoc Nurses AIDS Care. 2024 Jan-Feb 01;35(1):e1-e2. doi: 10.1097/JNC.0000000000000445. PMID: 38150573.

• Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study. Lopes SS, Pericot-Valverde I, Arnsten J, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Moschella P, Heo M, Litwin AH. Int J Drug Policy. 2023 Dec 15;123:104288. doi: 10.1016/j.drugpo.2023.104288. Online ahead of print. PMID: 38103458.

• Patient-centered Engagement as a Mediator in the Associations of Healthcare Discrimination, Pain Care Denial, and Later Substance Use Among a Sample of Predominately African Americans Living with HIV. Tseng TY, Mitchell MM, Chander G, Latkin C, Kennedy C, Knowlton AR. AIDS Behav. 2023 Dec 7. doi: 10.1007/s10461-023-04235-5. Online ahead of print. PMID: 38060111.

• Efficacy of Two Evidence-Based Alcohol Consumption Interventions on Positive, Negative, and Neutral Days Among Hazardous Alcohol Users Living with HIV in Vietnam. Chen JS, Hutton HE, Tran HV, Quang VN, Nguyen MX, Sripaipan T, Dowdy DW, Latkin CA, Chander G, Frangakis C, Go VF. AIDS Behav. 2023 Dec 12. doi: 10.1007/s10461-023-04234-6. Online ahead of print. PMID: 38085428.

• Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder. Foot C, Korthuis PT, Tsui JI, Luo SX, Chan B, Cook RR. Addiction. 2024 Jan;119(1):149-157. doi: 10.1111/add.16334. Epub 2023 Sep 15. PMID: 37712113.

• Shame and stigma in association with the HCV cascade to cure among people who inject drugs. Batchelder AW, Heo M, Foley JD, Sullivan MC, Lum P, Pericot Valverde I, Taylor LE, Mehta SH, Kim AY, Norton B, Tsui JI, Feinberg J, Page K, Litwin AH; HERO Study Group. Drug Alcohol Depend. 2023 Oct 31;253:111013. doi: 10.1016/j.drugalcdep.2023.111013. Epub ahead of print. PMID: 37951006.

• Influence of patient trust in provider and health literacy on receipt of guideline-concordant chronic opioid therapy in HIV care settings. Williams EC, Frost MC, Lodi S, Forman LS, Lira MC, Tsui JI, Lunze K, Kim T, Liebschutz JM, Rio CD, Samet JH. J Opioid Manag. 2023 Sep-Oct;19(5):385-393. doi: 10.5055/jom.0812. PMID: 37968972.

• Presentation and Outcomes of Adults with Overdose-Related Out-of-Hospital Cardiac Arrest. Vidhushei Yogeswaran, Christopher Drucker, Kosuke Kume, Amy Poel, Nicole Yarid, Sarah Leyde, Thomas D. Rea, Neal A. Chatterjee. JAMA Netw Open. 2023;6(11):e2341921. doi:10.1001/jamanetworkopen.2023.41921

• Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial. Wartko PD, Bobb JF, Boudreau DM, … Liebschutz JM, Tsui JI, Merrill JO, Lapham GT, Addis M, Bradley KA; PROUD Trial Collaborators; Ghiroli MM, Hamilton LK, Hu Y, LaHue JS, Loree AM, Murphy SM, Northrup TF, Shmueli-Blumberg D, Silva AJ, Weinstein ZM, Wong MT, Burganowski RP. JAMA Intern Med. 2023 Oct 30. doi: 10.1001/jamainternmed.2023.5701. Online ahead of print. PMID: 37902748.

• Adaptation of the collaborative care model to integrate behavioral health care into a low-barrier HIV clinic. Dombrowski JC, Halliday S, Tsui JI, Rao D, Sherr K, Ramchandani MS, Emerson R, Fleming M, Wood T, Chwastiak L. Implement Res Pract. 2023 Apr 17;4:26334895231167105. doi: 10.1177/26334895231167105. PMID: 37790178; PMCID: PMC10123894.

• Hepatitis C treatment in people living with HIV: Potential to eliminate disease and disparity. Falade-Nwulia O, Lesko CR, Fojo AT, Keruly JC, Moore RD, Sutcliffe CG, Mehta SH, Chander G, Thomas DL, Sulkowski M. J Infect Dis. 2023 Oct 5:jiad433. doi: 10.1093/infdis/jiad433. Online ahead of print. PMID: 37793170.

• Assessing the associations between known genetic variants and substance use in people with HIV in the United States. Haas CB, Jordahl KM, Nance RM, Whitney BM, Wang L, Delaney JAC, Ruderman S, Jia T, Mathews WC, Saag MS, Lee SA, Napravnik S, Jacobson JM, Chander G, McCall EM, Moore RD, Mayer KH, Mukherjee S, Lee WJ, Crane PK, Crane H, Peter I, Lindström S. PLoS One. 2023 Oct 5;18(10):e0292068. doi: 10.1371/journal.pone.0292068. eCollection 2023. PMID: 37796845.

• Racial disparities in use of syringe service programs in King County, WA: A comparison of two cross-sectional surveys. Katheryn Salow, Helen E. Jack, Joe Tinsley, Caleb J. Banta-Green, Susan Kingston, Matthew Iles-Shih, Judith I. Tsui & Sara Glick. Harm Reduct J 20, 133 (2023). https://doi.org/10.1186/s12954-023-00868-w.

• Weighing cessation: Rising adiposity of current smokers in NHANES. Ellison-Barnes A, Yeh HC, Pollack CE, Daumit GL, Chander G, Galiatsatos P, Gudzune KA. Prev Med. 2023 Sep 25:107713. doi: 10.1016/j.ypmed.2023.107713. Online ahead of print. PMID: 37758125.

• Critical care for patients with substance use disorders. Steel TL, Bhatraju EP, Hills-Dunlap K. Curr Opin Crit Care. 2023 Oct 1;29(5):484-492. doi: 10.1097/MCC.0000000000001080. Epub 2023 Jul 31. PMID: 37641506 Review.

• Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use. Pytell JD, Fojo AT, Keruly JC, Snow LN, Falade-Nwulia O, Moore RD, Chander G, Lesko CR. Addict Sci Clin Pract. 2023 Sep 2;18(1):51. doi: 10.1186/s13722-023-00408-8. PMID: 37660116.

• A Digital Counselor-Delivered Intervention for Substance Use Among People With HIV: Development and Usability Study. Hutton HE, Aggarwal S, Gillani A, Chander G. JMIR Form Res. 2023 Aug 28;7:e40260. doi: 10.2196/40260. PMID: 37639294.

• Methamphetamine use and utilization of medications for opioid use disorder among rural people who use drugs. Tsui JI, Whitney BM, Korthuis PT, Chan B, Pho MT, Jenkins WD, Young AM, Cooper HLF, Friedmann PD, Stopka TJ, de Gijsel D, Miller WC, Go VF, Westergaard R, Brown R, Seal DW, Zule WA, Feinberg J, Smith GS, Mixson LS, Fredericksen R, Crane HM, Delaney JA; Rural Opioid Initiative Consortium. Drug Alcohol Depend. 2023 Aug 2;250:110911. doi: 10.1016/j.drugalcdep.2023.110911. Epub ahead of print. PMID: 37549545.

• Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019. Lesko CR, Falade-Nwulia OO, Pytell JD, Hutton HE, Fojo AT, Keruly JC, Moore RD, Chander G. Addiction. 2023 Jul 25. doi: 10.1111/add.16301. Online ahead of print. PMID: 37491566.

• An Attendance-based Contingency Management Pilot Program for Veterans Experiencing Homelessness With Stimulant-associated Cardiomyopathy in Primary Care. Tuegel C, Farris SD, Kantner CW, Leyde S, DePhilippis D, Kennedy AJ. J Addict Med. 2023 Jun 1. doi: 10.1097/ADM.0000000000001186. Epub ahead of print. PMID: 37261905.

• Alcohol use and the longitudinal HIV care continuum for people with HIV who enrolled in care between 2011-2019. Lesko CR, Gnang JS, Fojo AT, Hutton HE, Mccaul ME, Delaney JA, Cachay ER, Mayer KH, Crane HM, Scott Batey D, Napravnik S, Christopoulos KA, Lau B, Chander G. Ann Epidemiol. 2023 Jul 11:S1047-2797(23)00139-4. doi: 10.1016/j.annepidem.2023.07.002. Online ahead of print. PMID: 37442307.

• Workload, Usability, and Engagement with a Mobile App Supporting Video Observation of Methadone Take-Home Dosing: Usability Study. Idrisov B, Hallgren KA, Michaels A, Soth S, Darnton J, Grekin P, Woolworth S, Saxon AJ, Tsui JI. JMIR Hum Factors. 2023 Jul 13;10:e42654. doi: 10.2196/42654. PMID: 37440298.

• Buprenorphine adherence and illicit opioid use among patients in treatment for opioid use disorder. Bhatraju EP, Radick AC, Leroux BG, Kim TW, Samet JH, Tsui JI. Am J Drug Alcohol Abuse. 2023 Jun 27:1-8. doi: 10.1080/00952990.2023.2220876. Online ahead of print. PMID: 37369019.

• Tobacco Smoking and Pack-years are Associated with Frailty Among People with HIV.  Ruderman SA, Odden MC, Webel AR, Fitzpatrick AL, Crane PK, Nance RM, … McCaul M, Chander G, Cachay E, Lober WB, Kritchevsky SB, Austad S, Landay A, Pandya C, Cartujano-Barrera F, Saag MS, Kamen C, Hahn AW, Kitahata MM, Delaney JA, Crane HM. J Acquir Immune Defic Syndr. 2023 Jun 26. doi: 10.1097/QAI.0000000000003242. Online ahead of print. PMID: 37368939.

• Substance Use and Mental Health Comorbidities and Receipt of Specialty Care Among Patients Enrolled in a Low-Barrier HIV Clinic. Altwies EE, Zinsli KA, Chwastiak L, Tsui JI, Bhatraju EP, Ramchandani MS, Golden MR, Dombrowski JC. AIDS Behav. 2023 Jun 23. doi: 10.1007/s10461-023-04110-3. Online ahead of print. PMID: 37351687.

• Changes in alcohol consumption reported on routine healthcare screenings are associated with changes in depression symptoms. Hallgren KA, Jack HE, Oliver M, Berger D, Bobb JF, Kivlahan DR, Bradley KA. Alcohol (Hanover). 2023 Jun 16. doi: 10.1111/acer.15075. Online ahead of print. PMID: 37326806.

• HIV stigma and disclosure of alcohol use to physicians: examining the mediating role of depression among persons living with HIV. Kane JC, Mauro PM, Hahn JA, Chander G, Tobin KE, Martins SS, Paniagua-Avila A, Latkin CA. AIDS Care. 2023 Jun 14:1-6. doi: 10.1080/09540121.2023.2214864. Online ahead of print. PMID: 37314960.

• Use of Video Directly Observed Therapy and Characteristics Associated With Use Among Patients Treated With Buprenorphine in an Office-based Setting. Radick AC, James J, Leroux BG, Kim TW, Saxon AJ, Samet JH, Tsui JI. J Addict Med. 2023 May-Jun 01;17(3):300-304. doi: 10.1097/ADM.0000000000001103. Epub 2022 Oct 25. PMID: 37267172 Clinical Trial.

• A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and Experiences. Karasz A, Merchant K, Arnsten J, Feinberg J, Kim AY, Lum PJ, McKee MD, Mehta SH, Meissner P, Norton BL, Page K, Pericot-Valverde I, Singh R, Stein E, Taylor LE, Tsui JI, Wagner K, Litwin A. J Med Internet Res. 2023 Jun 2;25:e38176. doi: 10.2196/38176. PMID: 37266986.

• Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study. Geist ML, Radick AC, Tsui JI, Blalock KL, Adwell A, Tamru E, Connolly NC, James JR. Addict Sci Clin Pract. 2023 May 25;18(1):33. doi: 10.1186/s13722-023-00389-8. PMID: 37231486.

• Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs. Kimberly L. Sue, Marek Chawarski, Leslie Curry, Ryan McNeil, Edouard Coupet Jr, Robert P. Schwartz, Christine Wilder, Judith I. Tsui, Kathryn F. Hawk, Gail D’Onofrio, Patrick G. O’Connor, David A. Fiellin, E. Jennifer Edelman. JAMA Netw Open. 2023;6(5):e2312718. doi:10.1001/jamanetworkopen.2023.12718.

• Training Providers of People Who Use Drugs to Offer Hepatitis C Treatment: A Washington State Initiative. James JR, Tsui JI. Substance Abuse. 2023;0(0). doi:10.1177/08897077231167047.

• Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department-Initiated Buprenorphine Programs. Sue KL, Chawarski M, Curry L, McNeil R, Coupet E Jr, Schwartz RP, Wilder C, Tsui JI, Hawk KF, D'Onofrio G, O'Connor PG, Fiellin DA, Edelman EJ. JAMA Netw Open. 2023 May 1;6(5):e2312718. doi: 10.1001/jamanetworkopen.2023.12718. PMID: 37163263.

• Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs. Tsui JI, Lum PJ, Taylor LE, Mehta SH, Feinberg J, Kim AY, Norton BL, Niu J, Heo M, Arnsten J, Pericot-Valverde I, Thomas A, Blalock KL, Radick A, Murray-Krezan C, Page K, Litwin AH; HERO Study Group. Drug Alcohol Depend. 2023 Apr 17;247:109878. doi: 10.1016/j.drugalcdep.2023.109878. Epub ahead of print. PMID: 37150144.

• "Another tool in the toolkit"-Perceptions, suggestions, and concerns of emergency service providers about the implementation of a supervised consumption site. Perlmutter D, Wettemann C, Fockele CE, Frohe T, Williams W, Holland N, Oliphant-Wells T, Meischke H, van Draanen J. Int J Drug Policy. 2023 May;115:104005. doi: 10.1016/j.drugpo.2023.104005. Epub 2023 Mar 25. PMID: 36972652.

• A qualitative study of people who use methamphetamine during the early COVID-19 pandemic to inform future ED harm reduction strategies. Morse SC, Fockele C, Huynh LN, Zatzick A, Whiteside LK. Int J Emerg Med. 2023 Apr 28;16(1):30. doi: 10.1186/s12245-023-00505-0. PMID: 37106338.

• Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder. Thakrar AP, Pytell JD, Stoller KB, Walters V, Weiss RD, Chander G. J Subst Use Addict Treat. 2023 Apr 21:209055. doi: 10.1016/j.josat.2023.209055. Online ahead of print. PMID: 37088398.

• Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder. D'Onofrio G, Edelman EJ, Hawk KF, Chawarski MC, Pantalon MV, Owens PH, Martel SH, Rothman R, Saheed M, Schwartz RP, Cowan E, Richardson L, Salsitz E, Lyons MS, Freiermuth C, Wilder C, Whiteside L, Tsui JI, Klein JW, Coupet E, O'Connor PG, Matthews AG, Murphy SM, Huntley K, Fiellin DA. JAMA Netw Open. 2023 Apr 3;6(4):e235439. doi: 10.1001/jamanetworkopen.2023.5439. PMID: 37017967.

• "Sign Me Up": A qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic. Darnton JB, Bhatraju EP, Beima-Sofie K, Michaels A, Hallgren KA, Soth S, Grekin P, Woolworth S, Tsui JI. Addict Sci Clin Pract. 2023 Mar 29;18(1):21. doi: 10.1186/s13722-023-00372-3. PMID: 36991506; PMCID: PMC10052285.

• Patient and stakeholder perspectives on impacts of the COVID-19 pandemic on HIV and mental health care delivery in South Africa. Alexandra L Rose, Yvonne A Ochieng, Helen E Jack, Anu Sangraula, Nonceba Ciya, Yuche Jacobs, Sibabalwe Ndamase, Kristen S Regenauer, Imani Brown, Abigail C Hines, Kim Johnson, Ingrid V Bassett, John A Joska, Jessica F Magidson, and Bronwyn Myers. International Journal of STD & AIDS. 2023;0(0). doi:10.1177/09564624231160581.

• Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations. Cook RR, Foot C, Arah OA, Humphreys K, Rudolph KE, Luo SX, Tsui JI, Levander XA, Korthuis PT. Addict Sci Clin Pract. 2023 Feb 14;18(1):11. doi: 10.1186/s13722-023-00364-3. PMID: 36788634; PMCID: PMC9930351.

  The experience of re-infection among people who inject drugs successfully treated for hepatitis C. Karasz A, Merchant K, Singh R, Thomas A, Borsuk C, McKee D, Duryea P, Kim AY, Mehta S, Norton BL, Page K, Pericot-Valverde I, Sedillo S, Stein ES, Taylor LE, Tsui J, Litwin A. J Subst Use Addict Treat. 2023 Mar;146:208937. doi: 10.1016/j.josat.2022.208937. Epub 2023 Jan 6. PMID: 36880897.

• Association between clinical measures of unhealthy alcohol use and subsequent year hospital admissions in a primary care population. Helen E. Jack, Malia M. Oliver, Douglas B. Berger, Jennifer F. Bobb, Katharine A. Bradley, Kevin A. Hallgren. Drug and Alcohol Dependence. Volume 245, 1 April 2023, 109821.

• Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine. Tsui JI, Stephens D, Collins B, Denisiuk E, Hallgren KA, Blalock KL, Klein JW, Jack HE, Merrill JO. J Addict Med. 2023 Jan 17. doi: 10.1097/ADM.0000000000001129. Epub ahead of print. PMID: 36728182.

• Ending Medical Complicity With Skilled-Nursing Facility Discrimination Against People With Opioid Use Disorder. Cohen SM, Joab R, Bolles KM, Friedman S, Kimmel SD. Ann Intern Med. 2023 Feb 7. doi: 10.7326/M22-3049. Online ahead of print. PMID: 36745883.

• Lessons from the implementation of a trauma center-based program to support primary care providers in managing opioids and pain after trauma hospitalization. Baldwin LM, Katers LA, Sullivan MD, Gordon DB, James A, Tauben DJ, Arbabi S. Trauma Surg Acute Care Open. 2023 Feb 20;8(1):e001038. doi: 10.1136/tsaco-2022-001038. eCollection 2023. PMID: 36844370.

• Effect of two counseling interventions on self-reported alcohol consumption, alcohol biomarker phosphatidylethanol (PEth), and viral suppression among persons living with HIV (PWH) with unhealthy alcohol use in Uganda: A randomized controlled trial. Hahn JA, Fatch R, Emenyonu NI, Sanyu N, Katusiime A, Levine B, John Boscardin W, Chander G, Hutton H, Camlin CS, Woolf-King SE, Muyindike WR. Drug Alcohol Depend. 2023 Jan 21;244:109783. doi: 10.1016/j.drugalcdep.2023.109783. Online ahead of print. PMID: 36706675.

• A Mixed-methods Evaluation of an Addiction/Cardiology Pilot Clinic With Contingency Management for Patients With Stimulant-associated Cardiomyopathy. Leyde, Sarah; Abbs, Elizabeth; Suen, Leslie W.; Martin, Marlene; Mitchell, Andreas; Davis, Jonathan; Azari, Soraya. Journal of Addiction Medicine ():10.1097/ADM.0000000000001110, December 16, 2022. | DOI: 10.1097/ADM.0000000000001110.

• Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs. Austin EJ, Gojic AJ, Bhatraju EP, Pierce KA, Pickering EI, Tung EL, Scott JD, Hansen RN, Glick SN, Stekler JD, Connolly NC, Villafuerte S, McPadden M, Deutsch S, Ninburg M, Kubiniec R, Williams EC, Tsui JI. Int J Drug Policy. 2022 Dec 13;111:103924. doi: 10.1016/j.drugpo.2022.103924. Online ahead of print. PMID: 36521197.

• Clinician Perceptions of Receiving Different Forms of Feedback on their Opioid Prescribing. Klaiman T, Nelson MN, Yan XS, Navathe AS, Patel MS, Refai F, Delgado MK, Pagnotti DR Jr, Liao JM. Am J Med Qual. 2023 Jan-Feb 01;38(1):1-8. doi: 10.1097/JMQ.0000000000000092. Epub 2022 Dec 29. PMID: 36579960 Clinical Trial.

• Substance use disorder treatment and technology access among people who use drugs in rural areas of the United States: A cross-sectional survey. Button D, Levander XA, Cook RR, Miller WC, Salisbury-Afshar EM, Tsui JI, Ibragimov U, Jenkins WD, Westergaard RP, Korthuis PT. J Rural Health. 2022 Dec 27. doi: 10.1111/jrh.12737. Online ahead of print. PMID: 36575145.